Suppr超能文献

中国仓鼠卵巢细胞突变体低密度脂蛋白受体缺陷表型的一个基因外抑制子的分离与鉴定

Isolation and characterization of an extragenic suppressor of the low-density lipoprotein receptor-deficient phenotype of a Chinese hamster ovary cell mutant.

作者信息

Reddy P, Krieger M

机构信息

Department of Biology, Massachusetts Institute of Technology, Cambridge 02139.

出版信息

Mol Cell Biol. 1989 Nov;9(11):4799-806. doi: 10.1128/mcb.9.11.4799-4806.1989.

Abstract

ldlC cells are low-density lipoprotein (LDL) receptor-deficient Chinese hamster ovary cell mutants which express pleiotropic defects in Golgi-associated glycosylation reactions. The dramatically reduced stability of the abnormally glycosylated LDL receptors in ldlC cells was shown to be due, in part, to rapid proteolysis and release of a large extracellular fragment of the receptor into the medium. A set of spontaneously arising LDL receptor-positive revertants of ldlC cells has been isolated. One of these, RevC-13, exhibits the glycosylation defects characteristic of the original ldlC mutant, suggesting that restoration of receptor activity was due to extragenic suppression. This suppression was due to a dramatic increase in the rate of LDL receptor synthesis rather than to an increase in the stability of the abnormally glycosylated receptors. Increased receptor synthesis was not due to receptor gene amplification. The increased LDL receptor activity was subject to normal sterol regulation. Analysis of the RevC-13 extragenic suppressor activity in a series of hybrid cells showed that RevC-13 suppression was a codominant trait that acted in cis to the LDL receptor structural gene (ldlA). Thus, the extragenic suppression in RevC-13 cells has defined a genetic element which is either part of or linked to the LDL receptor structural gene and which can control LDL receptor expression.

摘要

LdlC细胞是低密度脂蛋白(LDL)受体缺陷的中国仓鼠卵巢细胞突变体,在高尔基体相关的糖基化反应中表现出多效性缺陷。已证明LdlC细胞中异常糖基化的LDL受体稳定性显著降低,部分原因是受体快速蛋白水解并向培养基中释放大量细胞外片段。已分离出一组自发产生的LdlC细胞的LDL受体阳性回复突变体。其中一个回复突变体RevC-13表现出原始LdlC突变体特有的糖基化缺陷,这表明受体活性的恢复是由于基因外抑制。这种抑制是由于LDL受体合成速率显著增加,而不是异常糖基化受体稳定性的增加。受体合成增加并非由于受体基因扩增。增加的LDL受体活性受正常固醇调节。对一系列杂交细胞中RevC-13基因外抑制活性的分析表明,RevC-13抑制是一种共显性性状,对LDL受体结构基因(ldlA)起顺式作用。因此,RevC-13细胞中的基因外抑制定义了一个遗传元件,它要么是LDL受体结构基因的一部分,要么与之相连,并且可以控制LDL受体的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c500/363628/693bee417d62/molcellb00059-0225-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验